A variety of systemic diseases not generally considered as rheumatic diseases can involve joints and can create differential diagnostic dilemmas. These diseases are reviewed in this article. Current Opinion in Rheumatology
Review recent data supporting safety and efficacy of B-cell-depleting agents for RA, as illustrated by data presented at American College of Rheumatology 2007 Annual Meeting. Medscape Rheumatology
Rheumatoid arthritis is linked to increased CV risk. Endothelial dysfunction, a CV disease marker, occurs in some inflammatory diseases but this link has not been explored in RA patients; until now. Rheumatology
Hormone replacement therapy in postmenopausal women appears to affect neither the risk of developing rheumatoid arthritis (RA) nor the severity of arthritis, researchers report in the March 15th issue of Arthritis & Rheumatism. Reuters Health Information
